With such a great webcast provided by Resverlogix in New York City over the past week one struggles with options . In one hand the cutting edge science compels one to clutch there shares tightly (surrendering only when BoM results produces results ) On the other hand we have approximately 3 years to wait , I understand the delima ....

The question remains (many) will Resverlogix be granted a Nasdaq listing in the short term ? will the orphan indications (many) provide positive results and revunue ? will new regional deals surface ... so many things can effect Resverlogix share price what will you do ??

Stock